Company Search:
Advanced Search
Sponsored Links
Acorda Therapeutics, Inc. Company Snapshot
Acorda Therapeutics, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acorda Therapeutics with three other companies in this sector in the United States: BIO-TECHNE Corp (2018 sales of $642.99 million of which 66% was Biotechnology), Neurocrine Biosciences Inc ($451.24 million of which 100% was Therapeutics), and ALK-Abello A/S ($460.77 million of which 61% was SCIT/SLIT drops).

Sales Analysis. During the year ended December of 2018, sales at Acorda Therapeutics were $471.43 million. This is a decrease of 19.9% versus 2017, when the company's sales were $588.29 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acorda Therapeutics, Inc.
  Stock Performance Chart for Acorda Therapeutics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2020): 2.36
(Figures in U.S. Dollars)
1 Week 4.0%   13 Weeks 34.1%  
4 Weeks -2.1%   52 Weeks -86.2%  
Acorda Therapeutics, Inc. Key Data:
  Ticker: ACOR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 471,433,000
(Year Ending Jan 2019).
Employees: 474
  Currency: U.S. Dollars Market Cap: 112,125,030
  Fiscal Yr Ends: December Shares Outstanding: 47,510,606
  Share Type: Common Closely Held Shares: 881,666
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.